- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Metastatic breast cancer: Endocrine therapy landscape reshaped ; volume:07 ; number:04 ; year:2017 ; pages:144-152
Avicenna journal of medicine ; 07, Heft 04 (2017), 144-152
- Beteiligte Personen und Organisationen
-
Salkeni, Mohamad Adham
Hall, Samantha June
- DOI
-
10.4103/ajm.AJM_20_17
- URN
-
urn:nbn:de:101:1-2021090816260641988457
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Salkeni, Mohamad Adham
- Hall, Samantha June
Ähnliche Objekte (12)
![Endocrine therapy of breast cancer, [1]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
Endocrine therapy and growth regulation of breast cancer
Status of adjuvant endocrine therapy for breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
VAV3 mediates resistance to breast cancer endocrine therapy
p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
Endocrine therapy of breast cancer, 4.. / A. Goldhirsch (Ed.)
Endocrine therapy of breast cancer : experimental and clin. aspects
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
Endocrine therapy and growth regulation of breast cancer
Status of adjuvant endocrine therapy for breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
VAV3 mediates resistance to breast cancer endocrine therapy
p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
Endocrine therapy of breast cancer, 4.. / A. Goldhirsch (Ed.)
Endocrine therapy of breast cancer : experimental and clin. aspects
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
Endocrine therapy and growth regulation of breast cancer
Status of adjuvant endocrine therapy for breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
VAV3 mediates resistance to breast cancer endocrine therapy
p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
Endocrine therapy of breast cancer, 4.. / A. Goldhirsch (Ed.)